Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2013 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at 25th Annual ROTH Conference

CORAL GABLES, Fla., March 7, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J. McEnany, Catalyst's Chief Executive Officer, and Steven...
March 05, 2013 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations

CORAL GABLES, Fla., March 5, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel...
February 21, 2013 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Launches New Website

CORAL GABLES, Fla., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel...
February 11, 2013 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline

CORAL GABLES, Fla., Feb. 11, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel...
February 05, 2013 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at 15th Annual BIO CEO & Investor Conference

CORAL GABLES, Fla., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that the company will present at the 15th Annual BIO CEO & Investor...
December 27, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement

CORAL GABLES, Fla., Dec. 27, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it received a Nasdaq Staff Deficiency Letter, dated December 24, 2012,...
December 11, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Automatic Conversion of $5 Million Promissory Note Into Shares of Common Stock

CORAL GABLES, Fla., Dec. 11, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that it has issued 6,666,667 shares (the "Shares") of its authorized but...
November 15, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Third Quarter 2012 Financial Results

CORAL GABLES, Fla., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the third quarter and nine months ended September...
November 08, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II(b) Trial for Cocaine Addiction

CORAL GABLES, Fla., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced top-line results from its U.S. Phase II(b) clinical trial evaluating the use...
October 31, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into Strategic Collaboration for Firdapse(TM) in North America

BioMarin to Make $5 Million Strategic Equity Investment in Catalyst Catalyst Licenses North American Rights to Firdapse™, a Phase III Orphan Drug for the Treatment of Lambert-Eaton...